Squire Patton Boggs has added two new partners from Morrison & Foerster with a focus on pharmaceutical companies’ intellectual property fights, as the national debate over drug prices heats up.
David Manspeizer, who is based in New York, and Greg Chopskie, who is based in San Francisco, started April 29 as partners in the firm’s IP and technology practice, which has added several laterals over the last year.
The two new hires had been approached by other firms, said Chopskie. But Squire Patton Boggs proved to be the clear choice, the pair said in a joint interview.
“Everything about ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.